technology

Hims to Launch Testosterone Testing for Men Amid New Therapy Offerings

21 Ekim 2026Wired

Hims plans to introduce testosterone testing and replacement therapy, expanding into controlled substances.
Hims, a telehealth company, is set to expand its services by offering testosterone replacement therapy, which will be its initial venture into prescribing controlled substances. This move aims to address the growing demand for low testosterone testing among men.
By providing accessible testing and treatment options, Hims seeks to capitalize on the increasing awareness of men's health issues.
Telehealth has gained significant traction, especially following the COVID-19 pandemic, as more individuals seek convenient healthcare solutions. Hims' initiative to test and treat low testosterone levels aligns with a growing societal focus on men's health, but it also brings to light the challenges of ensuring saf…
Hims' decision to enter the testosterone replacement market reflects a broader trend in telehealth, where companies are increasingly willing to navigate the complexities of prescribing controlled substances. This could potentially reshape how men approach health issues that have historically been stigmatized.

NewsAI özeti

This article is for informational purposes only and should not be considered medical advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.